Global Next-Generation Sequencing (NGS) Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Next-Generation Sequencing (NGS) Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

According to our (Global Info Research) latest study, the global Next-Generation Sequencing (NGS) Services market size was valued at US$ 4431 million in 2023 and is forecast to a readjusted size of USD 11690 million by 2030 with a CAGR of 15.0% during review period.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

This report is a detailed and comprehensive analysis for global Next-Generation Sequencing (NGS) Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Next-Generation Sequencing (NGS) Services market size and forecasts, in consumption value ($ Million), 2019-2030

Global Next-Generation Sequencing (NGS) Services market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Next-Generation Sequencing (NGS) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Next-Generation Sequencing (NGS) Services market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Next-Generation Sequencing (NGS) Services

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Next-Generation Sequencing (NGS) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Next-Generation Sequencing (NGS) Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Next-Generation Sequencing (NGS) Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Market segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others

Market segment by players, this report covers
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Next-Generation Sequencing (NGS) Services product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Next-Generation Sequencing (NGS) Services, with revenue, gross margin, and global market share of Next-Generation Sequencing (NGS) Services from 2019 to 2024.

Chapter 3, the Next-Generation Sequencing (NGS) Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Next-Generation Sequencing (NGS) Services market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Sequencing (NGS) Services.

Chapter 13, to describe Next-Generation Sequencing (NGS) Services research findings and conclusion.